RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Surgical Science Sweden Revenue 2024

Surgical Science Sweden Revenue

945.16 M SEK

Surgical Science Sweden Dividend yield

Ticker

SUS.ST

ISIN

SE0014428512

WKN

A2P46G

In 2024, Surgical Science Sweden's sales reached 945.16 M SEK, a 7.06% difference from the 882.85 M SEK sales recorded in the previous year.

The Surgical Science Sweden Revenue history

YEARREVENUE (undefined SEK)GROSS MARGIN (%)
2029e2.5424,12
2028e2.1528,45
2027e1.8932,50
2026e1.3645,10
2025e1.1453,71
2024e0.9564,84
20230.8869,42
20220.866,23
20210.3772,51
20200.184,32
20190.182,33
20180.0774,84
20170.06107,23
20160.05112,20
20150.05113,75
20140.03120,65

Surgical Science Sweden Aktienanalyse

What does Surgical Science Sweden do?

Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Surgical Science Sweden's Sales Figures

The sales figures of Surgical Science Sweden originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Surgical Science Sweden’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Surgical Science Sweden's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Surgical Science Sweden’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Surgical Science Sweden Stock

How much revenue did Surgical Science Sweden generate this year?

Surgical Science Sweden has achieved a revenue of 945.16 M SEK this year.

How much was the turnover of the company Surgical Science Sweden compared to the previous year?

The revenue of Surgical Science Sweden has increased by 7.06% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Surgical Science Sweden?

The revenue of Surgical Science Sweden is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Surgical Science Sweden measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Surgical Science Sweden so important for investors?

The revenue of Surgical Science Sweden is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Surgical Science Sweden pay?

Over the past 12 months, Surgical Science Sweden paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgical Science Sweden is expected to pay a dividend of 0 SEK.

What is the dividend yield of Surgical Science Sweden?

The current dividend yield of Surgical Science Sweden is .

When does Surgical Science Sweden pay dividends?

Surgical Science Sweden pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgical Science Sweden?

Surgical Science Sweden paid dividends every year for the past 0 years.

What is the dividend of Surgical Science Sweden?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgical Science Sweden located?

Surgical Science Sweden is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgical Science Sweden from 5/24/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.

When did Surgical Science Sweden pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of Surgical Science Sweden in the year 2023?

In the year 2023, Surgical Science Sweden distributed 0 SEK as dividends.

In which currency does Surgical Science Sweden pay out the dividend?

The dividends of Surgical Science Sweden are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Surgical Science Sweden

Our stock analysis for Surgical Science Sweden Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.